NASDAQ · Price History

Dermata Therapeutics, Inc. (DRMA) Stock Price History & Returns

$0.54 NASDAQ: DRMA Market Cap $2.66M

Price history through Nov 18, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Dermata Therapeutics, Inc. (DRMA) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $0.54 sits 0% of the way up a 52-week range of $0.53 to $4.66; 88.4% below the 52-week high; below its 50-day moving average of $0.97; below its 200-day average of $1.23; a beta of 0.66 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-60.9%
6 months-57.1%
1 year-79.8%
3 years-99.5%
5 years-100.0%

Year by year

0 of 5 years closed higher than the year before. Closes are the last observation in each calendar year.

YearCloseChange
2026$0.54-75.2%
2025$2.18-84.8%
2024$14.30-84.4%
2023$91.50-90.7%
2022$981.60-76.5%

Monthly closing prices

The last 36 months, newest first. 8 of 36 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$0.54-29.9%
October 2026$0.77-30.6%
September 2026$1.11-8.3%
August 2026$1.21+3.4%
July 2026$1.17-12.7%
June 2026$1.34+3.1%
May 2026$1.30-2.3%
April 2026$1.33+3.1%
March 2026$1.29+7.5%
February 2026$1.20-46.7%
January 2026$2.25+3.2%
December 2025$2.18-30.6%
November 2025$3.14-8.2%
October 2025$3.42-29.6%
September 2025$4.86-15.3%
August 2025$5.74-11.0%
July 2025$6.45-2.9%
June 2025$6.64-7.8%
May 2025$7.20-17.2%
April 2025$8.70-9.4%
March 2025$9.60-15.8%
February 2025$11.40-7.3%
January 2025$12.30-14.0%
December 2024$14.30+26.8%
November 2024$11.28-7.9%
October 2024$12.25-13.7%
September 2024$14.20-18.4%
August 2024$17.40-46.0%
July 2024$32.20+34.7%
June 2024$23.90-37.7%
May 2024$38.35-23.9%
April 2024$50.40-18.2%
March 2024$61.65-9.5%
February 2024$68.10+0.9%
January 2024$67.50-26.2%
December 2023$91.50-18.4%

Dermata Therapeutics, Inc. (DRMA) price history — frequently asked questions

How has Dermata Therapeutics, Inc. performed over the last year?

Dermata Therapeutics, Inc. (DRMA) has fallen 79.8% over the last twelve months, measured on price alone.

What is Dermata Therapeutics, Inc.'s five-year return?

Over five years the DRMA share price has lost 100.0%, excluding dividends.

What is Dermata Therapeutics, Inc.'s 52-week range?

Over the last year Dermata Therapeutics, Inc. (DRMA) has traded between $0.53 and $4.66.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +36.7%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +88.3%INSM 1-year -36.3%UTHR 1-year +21.5%INCY 1-year +14.3%ALNY 1-year -67.7%ASND 1-year +24.5%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.